tapi 1 (Tocris)
Structured Review
Tapi 1, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tapi-1/TAPI+1/us12576135-230-124-125
Average 94 stars, based on 18 article reviews
Images
Related Articles
Cell Culture:Article Title: The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes Article Snippet: CD4 + T cells and monocytes were isolated using negative selection (130-0560533, 130-096-537; Miltenyi Biotec, Bisley, UK). .. CD4 + T cells were expanded for 8 days using anti-CD3/CD28 dynabeads (1131D; Thermo Fisher Scientific), and monocytes were cultured in Mo-DC differentiation medium (130-094-812; Miltenyi Biotec) and differentiated into immature dendritic cells (iDC) for 7 days; 1 × 10 5 expanded CD4 + T cells and 1 × 10 4 iDC were cocultured and stimulated with Staphylococcal enterotoxin B (SEB) (S4881; Sigma, Glasgow, UK) for 4 days in the presence of various concentrations of test antibodies, with or without inhibitors of ADAM10 (GI254023X, Tocris, Abingdon, UK, 3995) [ ] or Article Title: 2′-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood Article Snippet: Colonoids were cultured in matrigel (Growth factor reduced basement membrane matrix, #356231, Corning), and overlaid with IntestiCult organoid growth medium (#06005, STEMCELL Technologies). .. When YAMC and EGFR −/− MCE cells grew to 80 to 90% confluency, cells were cultured in serum-starved medium (RPMI 1640 medium containing 0.5% of FBS and 100 U/ml of penicillin and streptomycin) at 37°C for 18 h. Then cells were treated with 2′-FL (synthesized by our group, as previously described ) at 5–20 μg/mL, D-glucose at 20 μg/mL (#G7528, Sigma-Aldrich), lactose at 20 μg/mL (#L3625, Sigma-Aldrich), or L-fucose at 20 μg/mL (#225880010, Thermo Scientific) with or without co-treatment with murine TNF at 100 ng/mL (#AF-315-01A, Pepro Tech, Inc), cycloheximide at 1 μg/mL (#C7698, Sigma-Aldrich), H 2 O 2 at 50 μM (#H1009, Sigma-Aldrich), anti-HB-EGF antibody at 500 ng/mL (# MA5-23914, Thermo Fisher Scientific), or other:Article Title: The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4+ and CD8+ tumor-infiltrating lymphocytes Article Snippet: Tumor-infiltrating lymphocytes (TILs) often have upregulated expression of immune checkpoint receptors, such as programmed cell death 1 (PD-1) and lymphocyteactivation gene 3 (LAG-3).. Patients treated with antibodies targeting PD-1 or its ligand (PD-L1) can develop resistance or relapse, with LAG-3 upregulation on T cells being one possible mechanism.. FS118 is a tetravalent, bispecific antibody comprising a full-length IgG1 antiPD-L1 antibody with bivalent LAG-3-binding capability in the fragment crystallizable region. Article Title: 2′-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood Article Snippet: Synthesized:Article Title: 2′-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood Article Snippet: Colonoids were cultured in matrigel (Growth factor reduced basement membrane matrix, #356231, Corning), and overlaid with IntestiCult organoid growth medium (#06005, STEMCELL Technologies). .. When YAMC and EGFR −/− MCE cells grew to 80 to 90% confluency, cells were cultured in serum-starved medium (RPMI 1640 medium containing 0.5% of FBS and 100 U/ml of penicillin and streptomycin) at 37°C for 18 h. Then cells were treated with 2′-FL (synthesized by our group, as previously described ) at 5–20 μg/mL, D-glucose at 20 μg/mL (#G7528, Sigma-Aldrich), lactose at 20 μg/mL (#L3625, Sigma-Aldrich), or L-fucose at 20 μg/mL (#225880010, Thermo Scientific) with or without co-treatment with murine TNF at 100 ng/mL (#AF-315-01A, Pepro Tech, Inc), cycloheximide at 1 μg/mL (#C7698, Sigma-Aldrich), H 2 O 2 at 50 μM (#H1009, Sigma-Aldrich), anti-HB-EGF antibody at 500 ng/mL (# MA5-23914, Thermo Fisher Scientific), or Recombinant:Article Title: Crosstalk between purinergic receptor P2Y 11 and chemokine receptor CXCR7 is regulated by CXCR4 in human macrophages Article Snippet: The ATP analog ATPγS (Sigma Aldrich, St. Louis, MO, USA) and the suramin analog NF340 (Santa Cruz, Dallas, TX, USA) were utilized as P2Y 11 receptor agonist (20 μM) and antagonist (20 μM), respectively. .. Additional reagents employed in this study: the PDE4-selective inhibitor rolipram (10 μM) (Sigma-Aldrich), recombinant IL-1β (0.2 and 2 ng·ml − 1 ) (R&D Systems, Minneapolis, MN, USA), the selective EGFR tyrosine kinase inhibitors AG1478 (10 μM) (Sigma) and erlotinib (20 μM) (Cayman Chemical, Ann Arbor, MI, USA), the CXCR4 chemokine receptor antagonists mavorixafor (AMD 070; 2–10 μM), plerixafor (AMD 3100; 2–10 μM), which is also an allosteric agonist of CXCR7, and TC14012 (2–10 μM), which is also a potent CXCR7 agonist (all from MedChemExpress, Monmouth Junction, NJ, USA), the MEK/ERK inhibitor U0126 (10 μM) (Sigma), the ACKR3 (CXCR7) chemokine receptor agonist VUF11207 (100 nM) (MedChemExpress), the |

